NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM415039 Query DataSets for GSM415039
Status Public on Jun 11, 2009
Title Normal Puerto Rican control 3
Sample type RNA
 
Source name skin fibroblasts, passages #2 and 4
Organism Homo sapiens
Characteristics gender: female
genotype: Wild type for TWIST2
ethnicity: Puerto Rican
Biomaterial provider Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=GM00037
Growth protocol Skin biopsies were taken from patients and normal controls from the forearm region, digested with trypsin-EDTA (0.025%) at 37oC for 1 hour in a Petri Dish, trypsin was removed, and 1% collagenase type I in RPMI 1640 was added. The biopsy was cut in small pieces with a sterile scalpel and incubated 3 hrs at 37oC. Then, the tissue was centrifuged at 1200 rpm for 10 minutes at room temperature, the supernatant was discarded and replaced with growth media. We grew skin fibroblasts in DMEM supplemented with 10% Fetal Bovine Serum and L-glutamine, penicillin and streptomycin, in a tissue culture incubator at 5% CO2 and 37oC. We grew the cells until flasks were 50-80% confluent until RNA was prepared.
Extracted molecule total RNA
Extraction protocol Cells were lysed directly on the culture flask by adding the appropriate amount of RLT solution from the RNeasy kit (Qiagen), as recommended by the manufacturer. RNA was quantified in a Nanodrop system or a Pharmacia spectrophotometer. RNA quality was assessed using the Agilent Bioanalyzer using the RNA Nanoassay.
Label biotin
Label protocol Double-stranded cDNA synthesis, in vitro transcription/target labeling, hybridization/control mixture preparation, chip-hybridization, and post-processing procedures were performed using standard protocols from Affymetrix by the Mount Sinai School of Medicine Microarray Shared Research Facility.
 
Hybridization protocol Gene expression profiles of normal and SS patient fibroblasts were examined by microarray analysis using Affymetrix U133plus2.0 chips. The hybridization steps were performed by the Mount Sinai School of Medicine Microarray Shared Research Facility
Scan protocol GeneChips scans were performed by the Mount Sinai School of Medicine Microarray Shared Research Facility on an Affymetrix GeneChip system.
Description 1:1 Pool of two control cell lines, one is GM00037, the other is from a normal donor
Data processing A summarized dataset of the Affymetrix chips was obtained by GC Robust Multi-Chip Average (gcRMA) analysis for the background correction and normalization (Wu et al, 2004). We combined the Affymetrix data to assess consistent differences between the mutant and wild type fibroblasts gene expression and used the following three criteria to find candidate genes: a) the moderated t-statistic is not less than 332 (Gordon 2004); b) the average fold change is no less than two fold increase (or decrease); c) The maximum of the log 2 based signal intensities across the arrays was greater than 3.5, which was approximately twenty percentile of all log 2 based signal intensities. This step was done to filter out genes with extremely low expression levels.
 
Submission date Jun 09, 2009
Last update date Aug 28, 2018
Contact name Carmen Lydia Cadilla
E-mail(s) carmen.cadilla@upr.edu
Phone 7877544366
Organization name University of Puerto Rico School of Medicine
Department Biochemistry
Lab A640
Street address University of Puerto Rico Medical Sciences Campus, Area of Medical Center
City San Juan
State/province PR
ZIP/Postal code 00936
Country Puerto Rico
 
Platform ID GPL570
Series (1)
GSE16524 Expression data from skin fibroblasts derived from Setleis Syndrome patients and normal controls
Relations
Reanalyzed by GSE119087

Data table header descriptions
ID_REF
VALUE gcRMA normalized signal
ABS_CALL indicating whether the transcript was present (P), absent (A), or marginal (M)
DETECTION P-VALUE

Data table
ID_REF VALUE ABS_CALL DETECTION P-VALUE
AFFX-BioB-5_at 97.4832 P 0.000753643
AFFX-BioB-M_at 129.362 P 5.16732e-05
AFFX-BioB-3_at 81.1329 P 0.0012475
AFFX-BioC-5_at 506.788 P 5.16732e-05
AFFX-BioC-3_at 682.837 P 4.42873e-05
AFFX-BioDn-5_at 1159.79 P 4.42873e-05
AFFX-BioDn-3_at 2724.23 P 7.00668e-05
AFFX-CreX-5_at 5430.93 P 5.16732e-05
AFFX-CreX-3_at 6359.15 P 4.42873e-05
AFFX-DapX-5_at 4055.07 P 4.42873e-05
AFFX-DapX-M_at 6855.78 P 5.16732e-05
AFFX-DapX-3_at 8852.57 P 4.42873e-05
AFFX-LysX-5_at 8443.87 P 4.42873e-05
AFFX-LysX-M_at 10292.2 P 4.42873e-05
AFFX-LysX-3_at 10855.1 P 4.42873e-05
AFFX-PheX-5_at 1.21855 A 0.953518
AFFX-PheX-M_at 1.13877 A 0.949771
AFFX-PheX-3_at 14.7296 A 0.48511
AFFX-ThrX-5_at 1466.3 P 4.42873e-05
AFFX-ThrX-M_at 2367.44 P 4.42873e-05

Total number of rows: 54675

Table truncated, full table size 1631 Kbytes.




Supplementary file Size Download File type/resource
GSM415039.CEL.gz 4.9 Mb (ftp)(http) CEL
GSM415039.CHP.gz 298.5 Kb (ftp)(http) CHP
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap